Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Paul Breillat: New Insights Into the Role of RIPK1-Mediated Cell Death in VEXAS syndrome
Paul Breillat/LinkedIn
Jun 17, 2026, 17:45

Paul Breillat: New Insights Into the Role of RIPK1-Mediated Cell Death in VEXAS syndrome

Paul Breillat, Assistant Clinical Fellow in Internal Medicine and Clinical Immunology at Cochin Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood, adding:

“Excited to share our latest work, now published in Blood accompanied by an editorial.

Our study provides new insights into the role of RIPK1-mediated cell death in VEXAS syndrome and supports the rationale for evaluating RIPK1 inhibitors as a therapeutic strategy.

Many thanks to Benjamin Terrier for his mentorship and continued support, and to all our collaborators, in particular David Beck and Samuel Magaziner, for their invaluable contributions to this work.”

Title: Inflammatory cell death and monocyte dysfunction in VEXAS syndrome

Authors: Paul Breillat, Samuel J. Magaziner, Stéphane Camus, Léa Dionet, Benjamin De Valence, Pierre Sohier, Amine Majdi, Quentin Delcros, Federica Pallotti, Nadia Rivet, Kevin Chevalier, Margot Poux, Athena Lam, Pierre-Louis Tharaux, Olivia Lenoir, Abdelrahim Zoued, Olivier Kosmider, David B. Beck, Benjamin Terrier

Paul Breillat

Stay updated on all scientific advances with Hemostasis Today.

Abdelrahim Zoued Amine Majdi Athena Lam Benjamin De Valence Benjamin Terrier Blood David B. Beck David Beck Federica Pallotti Health Hematology Hemostasis News Hemostasis Today Kevin Chevalier Léa Dionet Margot Poux Medicine Nadia Rivet Olivia Lenoir Olivier Kosmider Paul Breillat Pierre Sohier Pierre-Louis Tharaux Quentin Delcros RIPK1 RIPK1 inhibitors Samuel J Magaziner Samuel Magaziner Stéphane Camus Vexas
NewsFeed